Background: Clinical, functional, and patient-oriented outcomes are commonly used to evaluate the efficacy of treatments after anterior cruciate ligament (ACL) injury; however, these evaluation techniques do not directly measure the biomechanical changes that occur with healing.
Current clinical, functional, and patient-oriented outcome assessments for evaluating the success of anterior cruciate ligament (ACL) treatments include hop testing, knee arthrometry, and patient-oriented outcome questionnaires. These assessment techniques have been useful in many clinical studies as a standardized way to evaluate the success of the treatment. 11 However, because these evaluation techniques are an indirect measure of graft health or integrity, they require large numbers of patients to provide sufficient power and to detect differences between treatment groups. The lack of sensitive outcome measures for clinical studies may be one reason why no improvements have been found in many clinical trials comparing outcomes of different ACL reconstruction techniques (eg, comparisons of graft type, 21 graft position, 1 rehabilitation, 2 or graft tension 11 ). Furthermore, most of these kneespecific outcome measures may not be sensitive enough to detect biomechanical changes in the graft itself during healing. As a result, ex vivo animal models are frequently used to determine the biomechanics of a reconstructed graft to 5-in-5 The American Journal of Sports Medicine, Vol. 43, No. 3 DOI: 10.1177/0363546514561435 Ó 2014 The Author(s) directly evaluate graft healing. 12, 23 However, ex vivo approaches require destructive testing and are not suitable for longitudinal in vivo use. This limitation makes a reliable, quantitative, in vivo method for determining the biomechanical performance of a graft during healing highly desirable in both research and clinical settings.
Magnetic resonance (MR)-derived measures of volume 13, 15 and signal intensity (SI) 3, 34 have been found to be independent predictors of graft or ligament failure properties. More specifically, the linear combination of graft volume and median SI has been found to correlate with the biomechanical properties measured via ex vivo mechanical testing and offers a more complete evaluation of ligament or graft integrity than either MR-derived variable alone. 3, 34 While a method that directly relates these MR-derived parameters to the graft biomechanical properties is an important finding, determining the relationship between a graft's MR parameters and a patient's knee-specific traditional outcomes will offer a graft-specific assessment to complement the existing clinical evaluation tools.
The objective of this study was to determine if the MR parameters (volume and SI) that have been used to predict the biomechanical properties of the graft 3,4 will predict clinical (anteroposterior [AP] knee laxity), functional (1legged hop for distance), and patient-oriented outcome measures (Knee Injury and Osteoarthritis Outcome Score [KOOS]) at 3 and 5 years after ACL reconstruction. 11 We hypothesized that the MR-derived parameters of graft volume and median SI will significantly predict these clinical, functional, and patient-oriented outcomes in a cohort of patients with ACL reconstruction. Results from this study will provide a translational link between ex vivo animal model data of graft healing and commonly used clinical assessment tools. Furthermore, these data could help in the development of a more objective test to determine the appropriateness of timing for athletes to return to sports.
METHODS

Patient Population
A subset of participants enrolled in an ongoing institutional review board-approved study investigating the effects of initial graft tension on long-term outcome of ACL reconstruction with autograft was used for this analysis (clinical trials identifier: NCT00434837). 11 Patients received either a high-tension or low-tension graft after an isolated unilateral ACL injury as previously described. 11 Postoperatively, all patients followed a standardized rehabilitation program designed to enable them to return to sport within 6 months. The primary study results at 3-year follow-up found no significant differences in the clinical, functional, and patient-oriented outcome measures between the high-and low-tension treatment groups. 11 Subsequently, all patients with complete traditional outcomes and MR scans were pooled for this analysis.
Of the 90 patients enrolled in the original clinical study, 11 64 completed an onsite visit to obtain the clinical and functional outcomes at the 3-year follow-up. Of these 64 patients, we collected MR images from 50. Of the 50 patients with complete traditional outcomes and MR scans, there were 27 scans that were confounded by metal artifact in the immediate area of the graft and were omitted, as it was not possible to obtain accurate volume and SI measurements. The study group at 3 years (n = 23; 10 men, 13 women) had a mean age of 23 6 9 years at time of surgery. Seventeen patients received bone-patellar tendonbone autograft obtained from the central third of the ipsilateral patellar tendon, and 6 received a 4-stranded autograft created from the semitendinosus and gracilis tendons. Ten received a low-tension graft, and 13 received a high-tension graft. Of the 23 patients with complete traditional outcomes and MR images obtained at 3 years, 17 returned for an onsite follow-up at 5 years. Of these 17 patients, 16 underwent MR imaging; none were excluded due to artifact. At 5-year follow-up, the study group (n = 16; 6 men, 10 women) had a mean age of 24 6 10 years at time of surgery. Eleven received bone-patellar tendon-bone autografts, and 5 received 4-stranded autografts. Seven received a low-tension graft, and 9 received a high-tension graft.
Traditional Outcomes
Clinical, functional, and patient-oriented outcomes were used to assess overall patient knee function and patient outcome and to establish the relationships with the MR parameters of graft healing.
Clinical Outcome. The AP knee laxity values for both knees were measured using an arthrometer (KT-1000: MEDmetric Corp) at 3-and 5-year follow-up. Anteriordirected shear loads were applied in succession to find the neutral position of the knee. Three manual maximum tests were then performed, and the displacement readings between -90 N of posterior shear load and the manual maximum anterior shear load were averaged. The AP knee laxity score was reported as the difference in displacement between the injured knee and the uninjured contralateral knee (AP laxity difference). One examiner, with more than 6 years of experience, performed all of the arthrometer measurements.
Functional Outcome. At each follow-up visit, patients performed the 1-legged hop test for distance independently 3 times, and the trials were averaged. 29 The mean hop distance of the injured knee was normalized to that of the uninjured contralateral knee to determine the patient's hop score (hop%).
Patient-Oriented Outcome. The KOOS 30 was implemented to assess patient-oriented outcomes of the cohort at both time points. The KOOS evaluates 5 domains: knee-related quality of life (KOOS-QoL), sports and recreation function (KOOS-Sport), pain (KOOS-Pain), symptoms (KOOS-Sym), and activities of daily living (KOOS-ADL). 30 
MRI Ligament Outcomes
The MR parameters volume and median SI, which have been used to predict the biomechanical properties of the graft, 3, 4 were used to quantify graft integrity. All MR images were acquired 3 and 5 years postoperatively using a surface knee coil on the same 3-T scanner (Siemens TIM Trio) using standardized protocol and acquisition parameters. A 3-dimensional T1-weighted FLASH sequence (repetition time/echo time/flip angle, 20 ms/7.6 ms/12°; field of view, 160 mm; matrix, 512 3 512 pixels, slice thickness/ gap, 1.5/0 mm; number of signal averages, 1; bandwidth, 130 Hz/pixel) was used. Scans with confounding metal artifact due to magnetic susceptibility effects in the immediate proximity to the graft were omitted from analysis. These artifacts were most likely generated from the metallic drill bits used for tunnel placement during the reconstruction procedure. Some patients did receive a metallic fixation screw, but in all cases the screw was sufficiently far from the intra-articular space to avoid direct issues with artifact and the ACL.
Each ACL graft was then manually segmented from the MR image stacks, and 3-dimensional models of the graft were created using commercially available software (Mimics 16.0; Materialize). 3 Summing the total number of ACL graft voxels provided an estimate of the whole graft volume (6.94 voxels = 1 mm 3 ). The median graft SI (grayscale value) was calculated for each patient and was normalized to the subject-specific SI of femoral cortical bone to minimize interscan variability. 3, 31 All graft segmentations, for both 3-and 5-year scans, were done by a single examiner with more than 5 years of experience. The images were randomly processed within a 6-month time period. Before the beginning of the study, the intraexaminer reliability was tested using 7 repeated scans of a human cadaveric knee and 4 repeated scans of a porcine reconstructed knee, and a coefficient of variation of \5.8% was observed for both volume and SI measures.
Data Analysis
Because median graft SI values were not normally distributed, values were log transformed (base 2) before analysis, as previously reported. 3 Both volume and median graft SI were included as independent variables in a first-order multiple linear regression model to predict the traditional outcome measures (ie, AP laxity difference, hop%, KOOS-QoL, KOOS-Sport, KOOS-Pain, KOOS-Sym, and KOOS-ADL). In addition to reporting the individual slope coefficients and the significance of the 2 predictors (volume and SI), the model R 2 is also presented as a measure of overall model performance. 9, 24 Regression diagnostics based on residual plots were used to evaluate the appropriateness of the linear model. 9 Randomness of residuals was accepted for all variables except KOOS-ADL, which was excepted because of the limited range of patient scores (most patients had perfect KOOS-ADL scores). Additionally, multicollinearity between volume and SI in the multiple regressions was assessed using the variance inflation factor (VIF) at both the 3-and 5-year time points; VIF values were 1.01 for 3-year and 1.11 for 5-year time points and were well below the recommended limit of 10, as stated in the literature. 20, 25 A VIF of 1 indicates a stable regression. Statistical analyses were performed using SAS statistical software (SAS Institute Inc).
RESULTS
Clinical Outcomes
Graft volume combined with median graft SI in a multiple linear regression model did not predict AP laxity difference at 3-year follow-up (Table 1) . Likewise, the combination of volume and median SI did not predict AP laxity difference at 5-year follow-up; however, it did approach significance (R 2 = 0.36, P = .088) ( Figure 1 and Table 1 ).
Functional Outcomes
Volume combined with median graft SI in a multiple linear regression model predicted hop% at 3-year follow-up (R 2 = 0.40, P = .008) ( Figure 2A and Table 1 ). The combination of volume and SI also predicted hop% at 5-year follow-up (R 2 = 0.62, P = .003) ( Figure 2B and Table 1 ).
Patient-Oriented Outcomes
At the 3-year follow-up, volume combined with median graft SI in a multiple linear regression model did not predict KOOS-QoL, KOOS-Sport, KOOS-Pain, KOOS-Sym, or KOOS-ADL (Table 1) . However, at 5-year follow-up, the combination of volume and SI predicted KOOS-QoL (R 2 = 0.49, P = .012) (Figure 3 ), KOOS-Sport (R 2 = 0.37, P = .048), KOOS-Pain (R 2 = 0.46, P = .017), and KOOS-Sym (R 2 = 0.45, P = .021) ( Table 1) . At 5-year follow-up, the linear combination of volume and median SI did not predict KOOS-ADL (Table 1) .
DISCUSSION
Knee arthrometry, hop testing, and patient-oriented outcome questionnaires have been useful for many clinical studies as a standardized way to evaluate overall patient knee outcome after ACL treatment 11 ; however, these evaluation techniques are knee-specific measures of joint and patient health but may lack the sensitivity to determine the biomechanical properties of the graft. A more specific measure of graft integrity would therefore be a useful complement to the already existing set of treatment evaluation tools. Using patients from an ongoing ACL reconstruction study, 11 we were able to show that the same MR parameters (volume and median SI) used to directly predict ex vivo biomechanical properties of the graft in an animal model 3, 4 have the ability to predict overall knee health in terms of functional and patient-oriented outcome measures in patients.
In general, for traditional outcomes at 5-year follow-up, larger grafts with lower median SI values were associated with better knee performance and surgical outcome (Figure 4) . For the functional outcome at 5-year follow-up, patients with higher hop% (reflecting better knee function) 28 tended to have larger grafts with lower median SI (Figure 2) . Similarly, for the KOOS-Sport, KOOS-Pain, KOOS-QoL, and KOOS-Sym subscores at 5-year followup, patients with larger graft volumes and lower SI had higher subscores (indicating better knee function) ( Figure  3 ). 6 At 5-year follow-up, patients with higher AP laxity difference scores (ie, more surgical knee laxity than the contralateral control), 5 while not significant, tended to have grafts with smaller volume and higher median SI ( Figure  1) . Previous research has shown larger graft or ligament volume 3, 13, 15 and lower graft or ligament SI 3,34 are correlated with higher strength or biomechanical properties. These results show that MR parameters that relate to graft biomechanical performance are also predictive of overall patient knee health and ACL reconstruction surgical outcomes.
At 3-year follow-up, the MR variables of volume and median SI were unable to predict clinical (AP laxity difference) or patient-oriented outcomes (KOOS subscores). These nonsignificant predictions at the 3-year follow-up, paired with lower observed standard deviations in both volume at the 3-year compared with the 5-year follow-up (volume: 618 vs 711 mm 3 ; SI: 0.39 vs 0.43, respectively), suggest that there may not be enough variability 7, 18 in patient graft volume and SI to predict traditional outcomes at this earlier time point. However, at 3-year follow-up, the prediction for hop% was significant. Additionally, we saw an increase in prediction between the 3-and 5-year hop% data, as indicated by increasing R 2 values (3-year R 2 = 0.40, 5-year R 2 = 0.62). Considering this increase in R 2 and the significant 5-year prediction of AP laxity difference and KOOS subscores (KOOS-Sport, KOOS-Pain, KOOS-QoL, and KOOS-Sym), these results suggest that patient graft volume and SI and are more heterogeneous at the 5-year follow-up time and may indicate that the graft is still remodeling at 3 years. The linear combination of graft volume and median graft SI were unable to predict the KOOS-ADL subscore at either 3-or 5-year follow-up. These results support previous research showing that the KOOS-ADL subscore has been reported to be the least indicative of patient surgical outcome. 6, 11 The relative contribution of the independent variables of graft volume and median graft SI was assessed with individual P values in the linear regression. 19 Median graft SI significantly contributed to the predictions for all 5-year traditional outcomes (all P .048) ( Table 1) , except the AP laxity difference and KOOS-ADL. SI was also significant at 3-year follow-up for the hop test. Median graft or ligament SI has shown to be a significant predictor of ex vivo biomechanical properties in an animal model, 3, 34 further indicating graft integrity as represented by median SI may reflect surgical outcomes. Graft volume was only a significant contributor for the hop test at 5-year follow-up and approached significance for the KOOS-Sport 5-year follow-up. Despite being a significant predictor in ex vivo models, 3, 13, 15 graft volume may not be as strong of a predictor in this study because of variations in patient graft type.
Analyses of variance (ANOVAs) were used to test for differences between patient graft type for both volume and SI. No significant differences were found with graft volume or SI between graft types. Additionally, ANOVAs were used to test for differences between the high tension and low tension group for both volume and SI. No significant differences were found with volume and SI between the tension groups. This finding reflects the lack of differences in the tension groups for the original clinical study. 11 Signal intensity has been used in prior clinical studies to evaluate ACL graft health and maturation after ACL reconstruction surgery. 10, 16, 22, 27, 32 More specifically, it was found that 4 years after ACL reconstruction, semiquantitative clinician-graded scores based on graft SI appearance were unable to predict knee laxity or the International Knee Documentation Committee clinical outcome score. The lack of correlation found in this prior study could be due to the semi-quantitative nature of the clinician-based grading system, 17, 27, 32 which may lack the specificity needed to detect subtle differences in graft integrity. Furthermore, the authors cited a study selection bias 32 where patient recruitment was done after ACL reconstruction surgery, which may have limited the patient population to those with positive surgical outcomes, limiting the variability in the treatment outcomes.
This study was limited by the use of the SI variable, which can vary depending on scanner hardware and MRI acquisition parameters. 8 To address this concern, we used the same MR imaging parameters and manufacturer (Seimens, 3T Trio) throughout the study. Furthermore, we normalized the graft SI values to that of cortical bone within each image to minimize concerns of variability between scan sessions. 3, 31 Another limitation was the metal artifact identified in some of the follow-up MR scans. To address this limitation, we omitted scans with confounding metal artifact. However, metal artifact is not uncommon in MR images of patients' knees after ACL reconstruction. 14, 33 The problem could be minimized in part with the use of nonmetallic fixation screws and flushing the joint to remove residual debris before closure. It was assumed the MR parameters (volume and median SI) used to directly predict ex vivo biomechanical properties of the graft in an animal model 3, 4 would directly translate to a human clinical population. However, ex vivo failure testing of the graft is not possible in a clinical population. Therefore, this study was built on the research performed in a porcine model. 26 For this study, we assumed that graft volume and SI were the only MR variables correlated with patient outcome. However, it is possible that MR analyses to directly quantify fiber alignment and orientation could bolster the predictions of patient outcomes. Also, finding that graft volume and SI were correlated with traditional outcomes does not imply causality. It is possible that, rather than graft MR appearance affecting patient traditional outcomes, poor patient surgical outcome caused graft changes that were then detected through MRI. Further research would be necessary to clarify this point. Finally, at this point it is unknown how time would affect the relationships between the independent variables (volume, SI) and traditional outcomes, as 3 and 5 years after ACL reconstruction may not be the ideal time to evaluate the healing process. Future studies will focus on earlier time points when the graft is expected to be actively remodeling. If the relationship between volume and SI and traditional outcomes is found to hold at earlier time points, it could allow clinicians to determine graft-specific health to determine if the graft is healed enough to return to sport.
Despite these limitations, the results from this study provide a valuable translational link between ex vivo animal model data and patient data collected in a clinical context. With further development, these data could be used as a more objective test to determine the appropriateness of timing for the athletes return to sports.
